Columbus Circle Investors’s Ionis Pharmaceuticals IONS Stock Holding History

Columbus Circle Investors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-362,032	Closed	-$23.1M	–	288
2015 Q1	$23.1M	Sell	362,032 -53,415	-13%	-$3.62M	0.16%	138
2014 Q4	$25.6M	Sell	415,447 -46,072	-10%	-$2.27M	0.18%	124
2014 Q3	$17.9M	Buy	461,519 +22,127	+5%	+$784K	0.13%	150
2014 Q2	$15.1M	Sell	439,392 -1,009,950	-70%	-$31.8M	0.1%	169
2014 Q1	$62.6M	Buy	1,449,342 +938,486	+184%	+$45.5M	0.42%	69
2013 Q4	$20.4M	Sell	510,856 -157,562	-24%	-$5.61M	0.14%	156
2013 Q3	$25.1M	Buy	+668,418	New	+$20M	0.18%	146

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Columbus Circle Investors's IONS Position: Q2 2015 in Review

Columbus Circle Investors sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 362,032 shares — an estimated $23.1M sold.

Columbus Circle Investors first reported a position in IONS in Q3 2013 and held it in 7 quarters. The position peaked at $62.6M in Q1 2014. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

Columbus Circle Investors reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Columbus Circle Investors sold 362,032 Ionis Pharmaceuticals shares in Q2 2015, an estimated $23.1M.
Columbus Circle Investors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 7 quarters.
Columbus Circle Investors's Ionis Pharmaceuticals position peaked at $62.6M in Q1 2014.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Columbus Circle Investors's 13F filing for Q2 2015, filed 5 Aug 2015.